46,XY DSD caused by a rare mutation of the 17-β-hydroxysteroid dehydrogenase type 3 gene

Italian Journal of Pediatrics

Volumn 33, Issue 1, 2007, Pages 13-16

  Faienza, Maria Felicia ^a,b   Giordani, L ^a   Acquafredda, A ^a   Leggio, S ^b   Todarello, O ^b   Trabucco, S ^c   D'Aniello, M ^a   Zecchino, C ^a   Delvecchio, M ^a   Cavallo, L ^a  

^a Unità Operativa B Trambusti   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c POLICLINICO   (Italy)

Author keywords

17 hydroxysteroid dehydrogenase type 3; Ambiguous genitalia; Intersex disorders; Mutation

Indexed keywords

17 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 3; ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; GONADAL DYSGENESIS; HOMOZYGOSITY; HUMAN; SCHOOL CHILD;

EID: 34547109644     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics 2006;118:488-500.
2. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
3. Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993;14:577-93.
4. Miller WL, Huang N, Pandey AV, Fluck CE, Agrawal V. P450 oxidoreductase deficiency: a new disorder of steroidogenesis. Ann N Y Acad Sci 2005;1061:100-8.
5. Gobinet J, Poujol N, Sultan C. Molecular action of androgens. Mol Cell Endocrinol 2002;198:15-24.
6. Noguchi K, Saito K. Disorder of androgen biosynthesis. Nippon Rinsho 2004;62:339-43.
7. Sultan C, Gobinet J, Terouanne B, Paris F, Belon C, Jalaguier S, et al. The androgen receptor: molecular pathology. J Soc Biol 2002 196:223-40.
8. Zajac JD, Chilco PJ. Transcriptional control and the regulation of endocrine genes. Clin Exp Pharmacol Physiol 1995;22:935-43.
9. Bertelloni S, Federico G, Hiort O. 17β-hydroxysteroid dehydrogenase-3 deficiency: genetiics, clinical findings, diagnosis and molecular biology. Ital J Pediatr 2004;30:32-8.
10. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MI, et al. Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996; 81:130-6.
11. Boehmer AL, Brinkmann AO, Sandkuijl LA, Halley DJ, Niermeijer MF, Andersson S, et al. 17β-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999;84:4713-21.
12. Rosler A, Silverstein S, Abeliovich D. A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab 1996;81:1827-31.
13. Cohen-Kettenis PT. Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 2005;34:399-410.
14. Balducci R, Toscano V, Wright F, Bozzalon F, Di Piero G, Maroder M, et al. Familial male pseudohermaphroditism with gynaecomastia due to 17β-hydroxysteroid dehydrogenase deficiency. A report of 3 cases. Clin Endocrinol 1985;23:439-44.
15. McKeever BM, Hawkins BK, Geissler WM, Wu L, Sheridan RP, Mosley RT, et al. Amino acid substitution of arginine 80 in 17β-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics. Biochim Biophys Acta 2002;1601:29-37.
16. Bilbao JR, Loridan L, Audi L, Gonzalo E, Castano L. A novel missense (R80W) mutation in 17-beta-hydroxysteroid dehydrogenase type 3 gene associated with male pseudohermaphroditism. Eur J Endocrinol 1998;139:330-3.
17. Rosler A. 17β-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population. Pediatric Endocrinology Reviews 2006;3(Suppl 3):455-61